Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular NAD+ pool restoration pathway refers to the set of biochemical processes that maintain and replenish intracellular levels of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in redox reactions, energy metabolism, DNA repair, gene expression regulation, and cell survival. The restoration of the NAD+ pool is essential for sustaining cellular health and function, especially under conditions where NAD+ is consumed or degraded by various enzymes. The pathway involves de novo synthesis, the Preiss-Handler pathway, and the salvage pathway, with key enzymes including NAMPT, NMNAT1-3, and NRK1/2. Targeting this pathway has therapeutic implications for age-related diseases, neurodegeneration, and metabolic disorders.
Supplementation of NAD+ precursors to enhance NAD+ biosynthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular NAD+ Pool Restoration Pathway (None).